Epidemiology of Chronic Hepatitis B Infection in the Cohort of College Students with Vaccination in Taiwan

After the mass vaccination project in Taiwan, the prevalence of the hepatitis B virus (HBV) infection for the college-aged population of 18 to 21 years is uncertain. We aimed to investigate the prevalence of hepatitis B markers in different birth cohorts. A total of 38,075 students in universities i...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Te-Wei Cheng, Jeng-Fu Yang, Yi-Yu Chen, Kuan-Ta Wu, Meng-Szu Lee, Hsiang-Ju Kuo, Tzu-Chun Lin, Chao-Ling Wang, Meng-Hsuan Hsieh, Chia-Yi Lin, Batbold Batsaikhan, Chi-Kung Ho, Chia-Yen Dai
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	HBV vaccine HBsAg anti-HBs
Online Access:	https://www.mdpi.com/2076-393X/11/2/348

Similar Items

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)

Analysis of S gene characteristic sequences and changes in properties of protein expression in HBV ASCs with low-level HBsAg
by: Yu Yu, et al.
Published: (2022-09-01)

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
by: Milan J. Sonneveld, et al.
Published: (2023-08-01)

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
by: Gian Paolo Caviglia, et al.
Published: (2021-11-01)

Rupestonic Acid Derivative YZH-106 Promotes Lysosomal Degradation of HBV L- and M-HBsAg via Direct Interaction with PreS2 Domain
by: Lanlan Liu, et al.
Published: (2024-07-01)

Hepatitis B Virus Chronic Infection in Blood Donors from Asian and African High or Medium Prevalence Areas: Comparison According to Sex
by: Jean-Pierre Allain, et al.
Published: (2022-03-01)

A Comparative study on the prevalence of HCC seromarkers among tribal and coastal population
by: Joseph Selvin, et al.
Published: (2010-03-01)

Seroprevalence of HIV-HBV Co-Infection
by: Suresh B. Sonth, et al.
Published: (2012-04-01)

Geographic distribution of HBsAg subtypes in Brazil Distribuição geográfica dos subtipos de antígenos de HBsAg no Brasil
by: Ana Maria Coimbra Gaspar, et al.
Published: (1987-06-01)

Comparative ELISA reagents for detection of hepatitis B surface antigen (HBsAg) Comparação de reativos para o teste de ELISA na evidenciação do antígeno de superfície de hepatite B
by: I. F. Camargo, et al.
Published: (1987-06-01)

Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
by: C Niederhauser, et al.
Published: (2008-03-01)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
by: Abhishek Aggarwal, et al.
Published: (2023-04-01)

Investigation of HBV DNA in HBsAg positive patients
by: Nihal Secil Bati, et al.
Published: (2017-12-01)

[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]
by: Roberto Patriarchi, et al.
Published: (2015-12-01)

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
by: Carla S. Coffin, et al.
Published: (2022-11-01)

Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies
by: Maria V. Konopleva, et al.
Published: (2021-05-01)

Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis
by: Ummi Maimunah, et al.
Published: (2024-05-01)

High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: a cross sectional study
by: Joel Manyahi, et al.
Published: (2017-04-01)

Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies
by: Jun Inoue, et al.
Published: (2019-05-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Prevalence of Hepatitis B Serum Markers in Young Military Recruits in Greece: A Comparison Study between 2005 and 2019 Cohorts
by: Nikolaos Papadopoulos, et al.
Published: (2021-11-01)

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
by: Minghui Li, et al.
Published: (2022-08-01)

Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report
by: Maki Ohkubo, et al.
Published: (2023-12-01)

The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapy
by: Yingfu Zeng, et al.
Published: (2024-03-01)

Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
by: Abdulbasit R. N. Abuzwaida, et al.
Published: (1987-08-01)

Hepatitis surface B antigen clearance induced by long-term tenofovir disoproxil fumarate monotherapy in chronic hepatitis B treatment: a meta-analysis and longitudinal modeling analysis
by: Weizhe Jian, et al.
Published: (2025-05-01)

HIGH PREVALENCE OF HBsAg CARRIERS IN A SPECIFIC COMMUNITY IN BULGARIA
by: Zahariy Krastev, et al.
Published: (2011-10-01)

Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Xiao Lin, et al.
Published: (2022-09-01)

Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers
by: Hong Li, et al.
Published: (2022-04-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression
by: Giuseppina Brancaccio, et al.
Published: (2021-04-01)

Perspectives and control of hepatitis B virus infection in Taiwan
by: Chih-Lin Lin, et al.
Published: (2015-10-01)

Mutational landscape of the surface antigen of hepatitis B virus in patients with hepatocellular carcinoma
by: Arwa Bagasi, et al.
Published: (2025-06-01)

Natural History and Hepatitis B Virus Surface Antigen (HBsAg) Spontaneous Seroclearance in Hepatitis B Virus e-Antigen (HBeAg)-Negative Patients with Inactive Chronic Infection: A Multicenter Regional Study from South Italy
by: Michele Barone, et al.
Published: (2023-09-01)

Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection
by: Ilaria Montali, et al.
Published: (2022-05-01)

Detection and prevalence of HBsAg and HBV DNA among visiting patients attending health facilities in Nigeria
by: Uchenna D. Abazuh, et al.
Published: (2023-07-01)

Using the Quantitative Determination of HbsAg to Monitor Antiviral Therapy of Chronic HBV-Infection
by: I.A. Zaitsev
Published: (2015-04-01)